CN1177605C - Pill for treating rheumatic carditis - Google Patents
Pill for treating rheumatic carditis Download PDFInfo
- Publication number
- CN1177605C CN1177605C CNB021308403A CN02130840A CN1177605C CN 1177605 C CN1177605 C CN 1177605C CN B021308403 A CNB021308403 A CN B021308403A CN 02130840 A CN02130840 A CN 02130840A CN 1177605 C CN1177605 C CN 1177605C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- present
- rheumatic heart
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a pill for treating rheumatic heart diseases. The present invention is a Chinese patent medicine for mainly treating various rheumatic heart diseases and uses Chinese herbal medicines such as white atractylodes rhizome, prepared rehmannia root, dogwood pulp, grassleaf sweetflag rhizome, schisandra fruit, Chinese arborvitae kernel, ginseng, tuckahoe, ophiopogon root, polygala, jujube seed, yam amd gordon euryale seed as raw materials. The present invention can effectively treat and radically cure rheumatic heart diseases and has very good therapeutic effect on other heart diseases. The present invention greatly improves the survival quality and time of patients and has high healing rehabilitation effect.
Description
Technical field
The present invention relates to a kind of pill for the treatment of rheumatic heart disease, is that the various rheumatic heart diseases of a kind of main treatment are the Chinese patent medicine of raw material with the Chinese herbal medicine.
Background technology
Rheumatic heart disease is a kind of commonly encountered diseases, and the patient can not be engaged in physical work, and serious can't take care of oneself, even dead.Current, treatment rheumatic heart disease Western medicine commonly used, these Western medicine not only cost an arm and a leg, and toxic and side effects is also higher, it is the work of always studying that rheumatic heart disease is treated in utilization Chinese herbal treatment or auxiliary smelting, but present medicine can only alleviate the patient suffering, can not effect a radical cure, and curative effect can not be satisfactory.
Summary of the invention
The purpose of this invention is to provide a kind of pill for the treatment of rheumatic heart disease, can treat and effect a radical cure rheumatic heart disease, and other heart disease is also had better curative effect.
Solution of the present invention is according to the rule of the traditional Chinese medical science to rheumatic heart disease treatment, i.e. the body resistance strengthening and constitution consolidating, the kidney invigorating collateral dredging, blood circulation promoting and blood stasis dispelling, detoxifcation pain relieving, hard masses softening and resolving and antiinflammatory curing rheumatism, the blood sugar lowering blood fat, the present invention forms according to above-mentioned rule, can the kidney invigorating collateral dredging, blood circulation promoting and blood stasis dispelling, the detoxifcation pain relieving, the antiinflammatory curing rheumatism again can the body resistance strengthening and constitution consolidating, the blood sugar lowering blood fat, hard masses softening and resolving.Radix Rehmanniae Preparata of the present invention, Fructus Corni enriching yin and nourishing kidney, tonifying blood and regulating menstruation; Radix Polygalae, Rhizoma Acori Graminei and Rhizoma Atractylodis Macrocephalae intelligence promoting and the mind tranquilizing, a surname's air to open key, the strongly fragrant eliminating phlegm that looses, wind-damp dispelling, dampness is stimulated the menstrual flow, and removing blood stasis with potent drugs is by blood, and the detoxifcation parasite killing grinds the long-pending painful abdominal mass that disappears, the detumescence convergence; Fructus Schisandrae Chinensis, Semen Euryales and the Rhizoma Dioscoreae antidiarrheal of astringing the lung, lung benefiting spleen invigorating, the arresting sweating that promotes the production of body fluid, reinforcing the kindey to control nocturnal emission; Clearing heat and relieving fidgetness was promoted the production of body fluid and was quenched one's thirst, nourishing the lung to arrest cough Radix Ophiopogonis; Ginseng qi-tonifying takes off admittedly, promoting the production of body fluid and inducing sedation of the mind, reuniting the fractured tendons and bones, blood circulation regulating, strong waist knee joint; Semen Ziziphi Spinosae and Semen Platycladi mind tranquilizing and the heart calming, tranquilizing by nourishing the heart, arresting sweating promotes the production of body fluid, and moisturizes; The Poria eliminating dampness and diuresis, tranquilizing mind, strengthening the spleen stomach; The present invention has eliminating evil just the wound, sets upright and does not stay heresy, the kidney invigorating collateral dredging, warm network blood-activating analgetic, intelligence promoting and the mind tranquilizing, a surname's air to open key, the strongly fragrant eliminating phlegm that looses, wind-damp dispelling, dampness is stimulated the menstrual flow, removing blood stasis with potent drugs is by blood, and the detoxifcation parasite killing is subsided a swelling and restrained, and the blood sugar lowering blood fat has the sick effect of good radical cure.
The present invention is the pill of being made by the following weight proportion raw material
19～49 parts of 25～55 parts of Fructus Corni of 25～55 parts of Radix Rehmanniae Preparata of the Rhizoma Atractylodis Macrocephalae
19～49 parts of 41～71 parts of Semen Platycladi of 41～71 parts of Fructus Schisandrae Chinensis of Rhizoma Acori Graminei
19～49 parts of 19～49 parts of Poria of Radix Ginseng 19～49 parts of Radix Ophiopogonis
19～49 parts of 19～49 portions of Rhizoma Dioscoreaes of 41～71 parts of Semen Ziziphi Spinosaes of Radix Polygalae
25～55 parts of Semen Euryaless
The weight proportion of each raw material of formula optimization of the present invention is
24～39 parts of 30～45 parts of Fructus Corni of 30～45 parts of Radix Rehmanniae Preparata of the Rhizoma Atractylodis Macrocephalae
24～39 parts of 36～61 parts of Semen Platycladi of 36～61 parts of Fructus Schisandrae Chinensis of Rhizoma Acori Graminei
24～39 parts of 24～39 parts of Poria of Radix Ginseng 24～39 parts of Radix Ophiopogonis
24～39 parts of 24～39 portions of Rhizoma Dioscoreaes of 36～61 parts of Semen Ziziphi Spinosaes of Radix Polygalae
30～45 parts of Semen Euryaless
The weight proportion of best each raw material of prescription of the present invention is
29 parts of 35 parts of Fructus Corni of 35 parts of Radix Rehmanniae Preparata of the Rhizoma Atractylodis Macrocephalae
29 parts of 51 parts of Semen Platycladi of 51 parts of Fructus Schisandrae Chinensis of Rhizoma Acori Graminei
29 parts of 29 parts of Poria of Radix Ginseng 29 parts of Radix Ophiopogonis
29 parts of 29 portions of Rhizoma Dioscoreaes of 51 parts of Semen Ziziphi Spinosaes of Radix Polygalae
35 parts of Semen Euryaless
Described medicament is a said pill on any pharmaceutics.
The present invention can be made into pill, and method for making is that mix homogeneously is made medicated powder with said herbal medicine drying and crushing to 120～200 order fine powders, more per 100 gram medicated powder is added 90 gram refined honeys, and the patent medicine of making every ball 7 grammes per square metres gets final product.Usually oral, one time one ball, a twice-daily.
Clinical drug of the present invention uses the result to show that following advantage is arranged;
1, the Chinese herbal medicine each component selected for use of the present invention meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment rheumatic heart disease of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and is nontoxic to human body.Show that through animal acute toxicity test underproof animal end sees any toxic reaction, its main organs does not have tangible change yet, and mice is 40g crude drug/kg to the maximum tolerated dose of medicine of the present invention, is 156 times of clinical people's consumption, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, and rich in proteins in the medicine, glucose, phlegmatic temperament, organic acid, fatty oil, vitamin and nearly tens seed amino acids also contain various trace elements such as ginsenoside and ferrum, are beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention can treat and effect a radical cure rheumatic heart disease effectively, and other heart disease is also had better curative effect, has improved patient's life quality and the time greatly, and higher healing rehabilitation efficacy is arranged.
For showing the therapeutic effect of medicine of the present invention, as follows through clinical test results to rheumatic heart disease; Treat various rheumatic heart patient 67 examples, radical cure rehabilitation 40 examples, produce effects 20 examples, effective 3 examples, invalid 4 examples, effective percentage reaches more than 93%.Treat other heart disease 40 examples, radical cure rehabilitation 27 examples, produce effects 8 examples, effective 3 examples, invalid 2 examples, effective percentage reaches more than 90%.
The specific embodiment
Take by weighing raw material by following proportioning;
Rhizoma Atractylodis Macrocephalae 35g Radix Rehmanniae Preparata 35g Fructus Corni 29g
Rhizoma Acori Graminei 51g Fructus Schisandrae Chinensis 51g Semen Platycladi 29g
Radix Ginseng 29g Poria 29g 29g Radix Ophiopogonis
Radix Polygalae 51g Semen Ziziphi Spinosae 29g Rhizoma Dioscoreae 29g
Semen Euryales 35g
Production method is as follows;
Method for making is that mix homogeneously is made medicated powder with said herbal medicine drying and crushing to 120～200 order fine powders, adds 90 gram refined honeys by per 100 gram medicated powder again, and the patent medicine of making every ball 7 grammes per square metres gets final product.Usually oral, one time one ball, a twice-daily.
Claims (3)
1, a kind of pill for the treatment of rheumatic heart disease is characterized in that it is made up of following components in weight percentage:
19～49 parts of 25～55 parts of Fructus Corni of 25～55 parts of Radix Rehmanniae Preparata of the Rhizoma Atractylodis Macrocephalae
19～49 parts of 41～71 parts of Semen Platycladi of 41～71 parts of Fructus Schisandrae Chinensis of Rhizoma Acori Graminei
19～49 parts of 19～49 parts of Poria of Radix Ginseng 19～49 parts of Radix Ophiopogonis
19～49 parts of 19～49 portions of Rhizoma Dioscoreaes of 41～71 parts of Semen Ziziphi Spinosaes of Radix Polygalae
25～55 parts of Semen Euryaless.
2, a kind of pill for the treatment of rheumatic heart disease according to claim 1, wherein the weight proportion of each component is:
24～39 parts of 30～45 parts of Fructus Corni of 30～45 parts of Radix Rehmanniae Preparata of the Rhizoma Atractylodis Macrocephalae
24～39 parts of 36～61 parts of Semen Platycladi of 36～61 parts of Fructus Schisandrae Chinensis of Rhizoma Acori Graminei
24～39 parts of 24～39 parts of Poria of Radix Ginseng 24～39 parts of Radix Ophiopogonis
24～39 parts of 24～39 portions of Rhizoma Dioscoreaes of 36～61 parts of Semen Ziziphi Spinosaes of Radix Polygalae
30～45 parts of Semen Euryaless.
3, a kind of pill for the treatment of rheumatic heart disease according to claim 1, wherein the weight proportion of each component is:
29 parts of 35 parts of Fructus Corni of 35 parts of Radix Rehmanniae Preparata of the Rhizoma Atractylodis Macrocephalae
29 parts of 51 parts of Semen Platycladi of 51 parts of Fructus Schisandrae Chinensis of Rhizoma Acori Graminei
29 parts of 29 parts of Poria of Radix Ginseng 29 parts of Radix Ophiopogonis
29 parts of 29 portions of Rhizoma Dioscoreaes of 51 parts of Semen Ziziphi Spinosaes of Radix Polygalae
35 parts of Semen Euryaless.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021308403A CN1177605C (en) | 2002-10-14 | 2002-10-14 | Pill for treating rheumatic carditis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021308403A CN1177605C (en) | 2002-10-14 | 2002-10-14 | Pill for treating rheumatic carditis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1413649A CN1413649A (en) | 2003-04-30 |
| CN1177605C true CN1177605C (en) | 2004-12-01 |
Family
ID=4746478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021308403A Expired - Fee Related CN1177605C (en) | 2002-10-14 | 2002-10-14 | Pill for treating rheumatic carditis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1177605C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110877B (en) * | 2012-12-10 | 2014-08-13 | 宋爱民 | Traditional Chinese medicine preparation for treating rheumatic heart disease |
| CN104547448A (en) * | 2015-01-23 | 2015-04-29 | 张成杰 | Traditional Chinese medicine composition for treating rheumatic heart disease |
-
2002
- 2002-10-14 CN CNB021308403A patent/CN1177605C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1413649A (en) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1861187A (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN1339313A (en) | Pure traditional Chinese medicine for relaxing muscles and tendons and promoting blood circulation | |
| CN100544761C (en) | A kind of medicine for the treatment of coronary heart disease | |
| CN103495042A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN1840160A (en) | Powder for resisting hyperosteogeny | |
| CN1177605C (en) | Pill for treating rheumatic carditis | |
| CN1824103A (en) | External use medicine for treating knocks and falls and bone joining | |
| CN1183942C (en) | Chinese medicine pill for treating cough | |
| CN1305508C (en) | Pill for treating coronary heart disease | |
| CN1090503C (en) | Medical capsule for treating rheumatism and building up body and its preparing process | |
| CN100346807C (en) | Fuming-washing Chinese medicine for treating bone joint disease | |
| CN1212149C (en) | Cinese material medical preparation for curing children' hyperkinetic symptom and the preparation process thereof | |
| CN100398143C (en) | Medicament for treating vitiligo | |
| CN1190224C (en) | Medicine for treating stomach trouble | |
| CN1275618C (en) | Chinese medicinal composition for treating sexual dysfunction | |
| CN1305505C (en) | Medicament for treating prostatauxe inflammation | |
| CN1172710C (en) | Pill capable of treating hepatogastric disease | |
| CN1408413A (en) | Pellet capable of curing infantile anorexia and convulsion | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN1209130C (en) | Medical preparation of treating necrosis of femoral head | |
| CN1172709C (en) | Medicine for treating rheumatalgia | |
| CN103381252B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis, and preparation method thereof | |
| CN104107377A (en) | Wind-dispelling collateral-activating liquid | |
| CN104013732A (en) | Soft capsules for treating rheumatoid diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041201 Termination date: 20121014 |